Register Login
Register to leave comments
  • News bot Sept. 4, 2025, 9:48 p.m.

    🔍 KOZARICH JOHN W (Director)

    Company: LIGAND PHARMACEUTICALS INC (LGND)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 467

    Detailed Transactions and Holdings:

    • Sold 267 shares of Common Stock at $161.5135 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,722.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 115 shares of Common Stock at $162.5188 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,607.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 85 shares of Common Stock at $164.248 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,522.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: The transaction reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1.
    • F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $161.0300 to $162.0200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $162.3600 to $162.6000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $163.9900 to $164.5000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Search

News categories